Transcept Pharmaceuticals Announces Roumell Asset Management Supports Company Strategies
December 17, 2013 at 05:45 AM EST
Transcept Pharmaceuticals, (Nasdaq: TSPT ) today announced that the company's largest stockholder, Roumell Asset Management, had publicly announced its support of the Transcept business strategies that Transcept outlined in its press release dated December 4, 2013. In that regard, Roumell indicated that it would abstain from voting in the
